Peer-reviewed paper in 2026 shows mycelial compounds effective against respiratory diseases?
One-OffHealth & MedicineScience2moManifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecastYes 81.4%
Forecasters
12
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 14 minutes ago
Nov 12, 25, 4:56 AM UTCDec 31, 26, 11:59 PM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Will a peer-reviewed paper analyzing UAP sensor data be published in a Nature-family journal before January 1, 2027?
Manifold MarketsDate first peer reviewed manuscript in Cell, Nature, or Science concludes SARS2 lab origin more likely than not (Set)
Manifold MarketsWill China unveil a peer reviewed surgical cure for Alzheimers by the end of 2026?
Manifold MarketsWill a graviton be directly observed in a peer-reviewed paper before 2100?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiHow many human H5N1 cases will be reported in the United States in 2026?
KalshiRules
Particularly against severe / pandemic-risk disease such as CoV-2, H5N1, or so on.
- Resolves YES if one is published which shows statistically significant effects using mushroom or mycelium-derived extracts or compounds.
- Otherwise NO at end of 2026.
